AI-Enhanced Probiotic Microvesicles for Personalized Therapeutics

The present invention integrates therapeutic microvesicles of probiotic bacteria with cutting-edge technologies like AI, IoT, blockchain, and novel materials to create a more powerful and personalized system for various health applications.

The original patent disclosed therapeutic microvesicles of probiotic bacteria, but its limitations include the lack of optimized therapeutic effect, inefficient production processes, and inadequate tracking and authentication mechanisms. The new inventive concept addresses these limitations by incorporating machine learning algorithms, IoT sensors, blockchain-based tracking, and novel materials to enhance the stability and bioavailability of the microvesicles.

The system comprises a therapeutic microvesicle of a probiotic bacteria, generated using a machine learning algorithm to optimize its therapeutic effect. The microvesicle production process involves culturing the probiotic bacteria in a growth medium, monitored by an IoT sensor to adjust the medium and optimize the production. The microvesicle is coated with a novel material to enhance its stability and bioavailability. A blockchain-based tracking system ensures the authenticity and integrity of the microvesicle. An AI-powered diagnostic tool identifies the specific health needs of a subject and tailors the microvesicle to those needs, enabling personalized medicine.

The new claims introduce the novel combination of machine learning algorithms, IoT sensors, blockchain-based tracking, and novel materials, which are not obvious from the original patent. The integration of these distinct technologies with the therapeutic microvesicles of probiotic bacteria provides a non-obvious and innovative solution.

Alternative embodiments may include using different AI algorithms, IoT sensors, or novel materials. Variations may involve integrating the system with other health-related technologies, such as wearables or telemedicine platforms, to further enhance its capabilities.

The AI-enhanced probiotic microvesicles have vast commercial potential in the healthcare industry, particularly in personalized medicine, gut health, and immune system modulation. The system can be marketed to pharmaceutical companies, healthcare providers, and consumers seeking advanced therapeutic solutions.